Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2009-11-04
2010-06-29
Pak, Michael (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
Reexamination Certificate
active
07745583
ABSTRACT:
A neutralizing epitope is identified within amino acids 40-64 of the mature form of human myostatin. Antibodies that bind this epitope with high affinity preferentially bind GDF-8 over GDF-11 and may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful for increasing muscle mass, increasing hone density, or for the treatment of various disorders in mammalian and avian species.
REFERENCES:
patent: 5639638 (1997-06-01), Wozney et al.
patent: 5700911 (1997-12-01), Wozney et al.
patent: 5827733 (1998-10-01), Lee et al.
patent: 5914234 (1999-06-01), Lee et al.
patent: 6096506 (2000-08-01), Lee et al.
patent: 6340668 (2002-01-01), Celeste et al.
patent: 6368597 (2002-04-01), Strassmann et al.
patent: 6437111 (2002-08-01), Wozney et al.
patent: 6468535 (2002-10-01), Lee et al.
patent: 6500664 (2002-12-01), Lee et al.
patent: 6517835 (2003-02-01), Lee et al.
patent: 6656475 (2003-12-01), Lee et al.
patent: 6696260 (2004-02-01), Lee et al.
patent: 6858208 (2005-02-01), Lee et al.
patent: 7175997 (2007-02-01), Wozney et al.
patent: 7179884 (2007-02-01), Lee et al.
patent: 7261893 (2007-08-01), Veldman et al.
patent: 7320789 (2008-01-01), Dunham et al.
patent: 7371726 (2008-05-01), Junker et al.
patent: 7504490 (2009-03-01), Weinstock et al.
patent: 7511012 (2009-03-01), Han et al.
patent: 7534432 (2009-05-01), Lee et al.
patent: 7585648 (2009-09-01), Junker et al.
patent: 2002/0150577 (2002-10-01), Lee et al.
patent: 2003/0138422 (2003-07-01), Aghajanian et al.
patent: 2004/0142382 (2004-07-01), Veldman et al.
patent: 2004/0181033 (2004-09-01), Han et al.
patent: 2005/0014733 (2005-01-01), Whittemore et al.
patent: 2005/0043232 (2005-02-01), Lee et al.
patent: 2005/0143306 (2005-06-01), Junker et al.
patent: 2006/0034831 (2006-02-01), Tobin
patent: 2006/0240487 (2006-10-01), Nowak et al.
patent: 2006/0263354 (2006-11-01), Chin et al.
patent: 2007/0087000 (2007-04-01), Walsh et al.
patent: 2007/0149458 (2007-06-01), Han et al.
patent: 2007/0178095 (2007-08-01), Smith et al.
patent: 2007/0190056 (2007-08-01), Kambadur et al.
patent: 2008/0051328 (2008-02-01), Sharma et al.
patent: 2008/0187543 (2008-08-01), Kambadur et al.
patent: 2008/0299126 (2008-12-01), Han et al.
patent: 2009/0017045 (2009-01-01), Lee et al.
patent: 2009/0017522 (2009-01-01), Lee et al.
patent: 2009/0131638 (2009-05-01), Davies et al.
patent: 2009/0136481 (2009-05-01), Kambadur et al.
patent: 2009/0215671 (2009-08-01), Calof et al.
patent: 2009/0220491 (2009-09-01), Han et al.
patent: 2009/0311282 (2009-12-01), Junker et al.
patent: 1333035 (2003-08-01), None
patent: 2333706 (1999-04-01), None
patent: 94/21681 (1994-09-01), None
patent: 94/26892 (1994-11-01), None
patent: 96/01845 (1996-01-01), None
patent: 9835019 (1998-08-01), None
patent: 99/06559 (1999-02-01), None
patent: 99/24058 (1999-05-01), None
patent: 99/40181 (1999-08-01), None
patent: 00/43781 (2000-07-01), None
patent: 02/09641 (2002-02-01), None
patent: 02/10214 (2002-02-01), None
patent: 03/027248 (2003-04-01), None
patent: 2004/037861 (2004-05-01), None
patent: 2004/058988 (2004-07-01), None
patent: 2004/108157 (2004-12-01), None
patent: 2005066204 (2005-07-01), None
patent: 2005/094446 (2005-10-01), None
patent: 2006020884 (2006-02-01), None
patent: 2006/116269 (2006-11-01), None
patent: 2007/024535 (2007-03-01), None
patent: 2007/047112 (2007-04-01), None
patent: 2007044411 (2007-04-01), None
patent: 2007067616 (2007-06-01), None
patent: 2008030706 (2008-03-01), None
patent: 2008109167 (2008-09-01), None
Ashmore, et al., “Comparative Aspects of Muscle Fiber Types in Fetuses of the Normal and ‘Double-Muscled’ Cattle,” Growth 38:501-506 (1974).
Bogdanovich, et al., “Functional Improvement of Dystrophic Muscle by Myostatin Blockade,” Nature 420:418-421 (2002).
Bogdanovich, et al., “Therapeutics for Duchenne Muscular Dystrophy: Current Approaches and Future Directions,” J. Mol. Med. 82:102-115 (2004).
Gamer, et al., “Gdf11 is a Negative Regulator of Chondrogenesis and Myogenesis in the Developing Chick Limb,” Dev. Biol. 229:407-420 (2001).
Gamer, et al., “A Novel BMP Expressed in Developing Mouse Limb, Spinal Cord, and Tail Bud Is a Potent Mesoderm Inducer inXenopusEmbryos,” Dev. Biol. 208:222-232 (1999).
Gonzalez-Cadavid, et al., “Organization of the Human Myostatin Gene and Expression in Healthy Men and HIV-Infected Men With Muscle Wasting,” PNAS 95:14938-14943 (1998).
Gonzales-Cadavid, et al., “Role of Myostatin in Metabolism,” Curr. Opin. Clin. Nutr. Metab. Care 7:451-457 (2004).
Grobet, et al., “A Deletion in the Bovine Myostatin Gene Causes the Double-Muscled Phenotype in Cattle,” Nature Genet. 17:71-74 (1997).
Hamrick, et al., “Femoral Morphology and Cross-Sectional Geometry of Adult Myostatin-Deficient Mice,” Bone 27:343-349 (2000).
Hamrick, et al., “Bone Mineral Content and Density in the Humerus of Adult Myostatin-Deficient Mice,” Calcif. Tissue Int. 71(1):63-68 (2002).
Hill, et al., “The Myostatin Propeptide and the Follistatin-Related Gene Are Inhibitory Binding Proteins of Myostatin in Normal Serum,” J. Biol. Chem. 277:40735-40741 (2002).
Hill, et al., “Regulation of Myostatin in Vivo by Growth and Differentiation Factor-Associated Serum Protein-1: A Novel Protein with Protease Inhibitor and Follistatin Domains,” Mol. Endocrinol. 17:1144-1154 (2003).
Hoodless, et al., “Mechanisms and Function of Signaling by the TGFbeta Superfamily,” Current Topics in Microbiology and Immunology pp. 236-272 (1998).
Huet, et al., “Skeletal Muscle Cell Hypertrophy Induced by Inhibitors of Metalloproteases; Myostatin as a Potential Mediator,” Am. J. Physiol. Cell. Physiol. 281:C1264-C1634 (2001).
Jiang, et al., “Characterization and Identification of the Inhibitory Domain of GDF-8 Propeptide,” Biochem. Biophys. Res. Commun. 315:525-531 (2004).
Kambadur, et al., “Mutations in Myostatin (GDF8) In Double-Muscled Belgian Blue and Piedmontese Cattle,” Genome Res. 7:910-915 (1997).
Kim, et al., “Inhibition of Preadipocyte Differentiation by Myostatin Treatment in 3T3-L1 Cultures,” Biochem. Biophys. Res. Comm., 281:902-906 (2001).
Kingsley, D.M., “The TGFbeta Superfamily: New Members, New Receptors, and New Genetic Tests of Function in Different Organisms,” Genes & Devel. 8:133-146 (1994).
Kirk, et al., “Myostatin Regulation During Skeletal Muscle Regeneration,” J. Cell. Physiol., 184:356-363 (2000).
Lang, et al., “Regulation of Myostatin by Glucocorticoids After Thermal Injury,” FASEB J. 15:1807-1809 (2001).
Lee, et al., “Regulation of Myostatin Activity and Muscle Growth,” PNAS 98:9306-9311 (2001).
Li, et al., “Elimination of Myostatin Does Not Combat Muscular Dystophy in dy Mice but Increases Postnatal Lethality,” AJP. 166 (2) 491-497.
Lin, et al., “Myostatin Knockout in Mice Increases Myogenesis and Decreases Adipogenesis,” Biochem. Biophys. Res. Comm., 291:701-706 (2002).
Massagué, J., “The Transforming Growth Factor-beta Family,” Ann. Rev. Cell Biol. 6:597-641 (1990).
McPherron, et al., “Double Muscling in Cattle Due to Mutations in the Myostatin Gene,” PNAS 94:12457-12461 (1997).
McPherron, et al., “Regulation of Skeletal Muscle Mass in Mice by a New TGF-beta Superfamily Member,” Nature 387:83-90 (1997).
McPherron, et al., “Suppression of Body Fat Accumulation in Myostatin-Deficient Mice,” J. Clin. Invest. 109:595-601 (2002).
Muscaritoli, et al., “Therapy of Muscle Wasting in Cancer: What Is The Future?” Curr. Opin. Clin. Nutr. Metab. Care, 7:459-466 (2004).
Nakashima, et al., “Expression of Growth/Differentiation Factor 11, A New Member of the BMP/TGF beta Superfamily During Mouse Embryogenesis,” Mech. Dev. 80:185-189 (1999)
Han Bomie
Korytko Andrew Ihor
Mitchell Pamela Jean
O'Bryan (Nee Tobias) Linda
Smith Rosamund Carol
Eli Lilly and Company
Pak Michael
Wiskerchen MaryAnn
LandOfFree
Anti-myostatin antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-myostatin antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-myostatin antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4178319